Short Interest in Ambu A/S (OTCMKTS:AMBBY) Declines By 33.3%

Ambu A/S (OTCMKTS:AMBBY) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 200 shares, a decline of 33.3% from the August 31st total of 300 shares. Based on an average daily trading volume, of 400 shares, the days-to-cover ratio is presently 0.5 days.

Ambu A/S Price Performance

Ambu A/S stock remained flat at $19.60 during mid-day trading on Friday. The company had a trading volume of 1 shares, compared to its average volume of 583. The stock’s 50-day moving average is $20.07 and its 200 day moving average is $18.62. The company has a current ratio of 2.52, a quick ratio of 1.51 and a debt-to-equity ratio of 0.09. The firm has a market cap of $4.61 billion and a P/E ratio of 98.00. Ambu A/S has a 1 year low of $9.45 and a 1 year high of $22.65.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings data on Friday, August 30th. The company reported $0.07 earnings per share (EPS) for the quarter. Ambu A/S had a net margin of 8.55% and a return on equity of 8.09%. The firm had revenue of $199.56 million during the quarter.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.